BioLineRx, Exclusive BioLineRx entered Exclusive License Agreement to Motixafortide in Asia, advisored by M.S.Q. Ventures 07.08.2025 - 18:04:13 MSQ Ventures New York United States of America Israel View original content:https://www.prnewswire.co.uk/news-releases/biolinerx-entered-exclusive-license-agreement-to-motixafortide-in-asia-advisored-by-msq-ventures-301972254.html
